Taiwan Cooperative Oncology Group   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Taipei Taiwan (1989)

Organization Overview

First Clinical Trial
1994
NCT00201344
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Pancreatic Cancer Disease Committee of Taiwan Cooperative Oncology Group | Taiwan cooperative oncology group | Taiwan Cooperative Oncology Group, National Health Research Institutes | Taiwan Cooperative Oncology Group, NHRI | Taiwanese Cooperative Oncology Group

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 3)

Nasopharyngeal Carcinoma (Phase 3)

Pancreatic Neoplasms (Phase 2)

Prostatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 10
  • # of Trial APIs: 23